EpiPen Recalled in Australia


Alphapharm, the Australian subsidiary of Mylan, has recalled four batches of EpiPen brand 300µg epinephrine auto-injectors for a potentially defective part after two of the devices failed to activate, according to a report by ABC News, Australia.

The recalled product was manufactured by Meridian Medical Technologies in St. Louis Missouri and the devices have been distributed worldwide.

“The failure of the auto-injector to activate may result in patients not receiving the required dose of adrenaline, resulting in the worsening of symptoms of anaphylaxis or anaphylactic reactions, which could be life-threatening,” the company said.

Click to visit sponsor

The affected batches are:

Batch number Expiry
5FA665 April 2017
5FA6651 April 2017
5FA6652 April 2017
5FA6653 April 2017

We presume these batches have been in circulation for a while since the expiration dates are imminent.

Alphapharm said: “At this time, EpiPen Jr 150 microgram adrenaline injection syringe auto-injectors and all other batches of EpiPen 300 microgram adrenaline injection syringe auto-injectors are unaffected and are not subject to this recall.”

As of this writing, a recall has not been initiated in the US.

Print or share this article
Print or share this article
Click to visit sponsor
Dave Bloom
Dave Bloom
Dave Bloom is CEO and "Blogger in Chief" of SnackSafely.com.

Find Allergy-Friendly Products


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.